Has results × Breast Neoplasms × Zoledronic Acid × Clear all Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid
Phase 3 Completed
1,803 enrolled 20 charts
Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy
Phase 3 Completed
3,420 enrolled 19 charts
A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.
Phase 3 Completed
2,049 enrolled 16 charts
Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone Metastasis
Phase 1/2 Completed
31 enrolled 8 charts
S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.
Phase 3 Completed
6,097 enrolled 20 charts
Zoledronate in Treating Bone Marrow Micrometastases in Women With Stage I, Stage II, or Stage III Breast Cancer
Phase 2 Completed
45 enrolled 9 charts
Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic Acid
Phase NA Terminated
9 enrolled 3 charts
Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer
Phase 2 Completed
68 enrolled 11 charts
Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast Cancer
Phase NA Completed
60 enrolled 23 charts
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
Phase 3 Completed
1,822 enrolled 19 charts
Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms
Phase 2 Completed
63 enrolled 7 charts
A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)(0822-016)(COMPLETED)
Phase 2 Completed
43 enrolled 10 charts
Extended Endocrine Therapy for Premenopausal Women With Breast Cancer
Phase 2 Completed
17 enrolled 5 charts
The Safety and Efficacy of Zoledronic Acid in the Prevention of Cancer Therapy Induced Bone Loss
Phase 3 Completed
70 enrolled 25 charts
A Study of Zoledronic Acid in the Prevention of Cancer Therapy-induced Bone Loss
Phase 4 Terminated
11 enrolled 6 charts
Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer
Phase 3 Completed
416 enrolled 10 charts
CTIBL
Phase 3 Completed
18 enrolled 5 charts
Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.
Phase 3 Completed
1,065 enrolled 10 charts
The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer
Phase 3 Completed
527 enrolled 11 charts
Safety and Efficacy of Zoledronic Acid in Patients With Breast Cancer With Metastatic Bone Lesions
Phase 3 Completed
430 enrolled 12 charts
Safety/Efficacy of Letrozole Monotherapy or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer
Phase 3 Completed
83 enrolled 14 charts